SLC2A5, solute carrier family 2 member 5, 6518

N. diseases: 48; N. variants: 2
Disease: Metabolic Diseases ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases 		0.020 AlteredExpression group BEFREE As a ligand-activated transcription factor, LXRα might provide novel pharmacologic strategies for the selective modulation of GLUT5 activity in the treatment of metabolic disease as well as cancer. 31243309 2019
CUI: C0025517
Disease: Metabolic Diseases
Metabolic Diseases 		0.020 Biomarker group BEFREE Fructose transporter GLUT5 is characterized by unusual substrate specificity and is linked to a variety of metabolic disorders. 30113044 2018